IBX vs NEU

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

IBX

IMAGIONBIO FPO [IBX]

44LOW

NEU

NEUREN FPO NZ [NEU]

44LOW

Score Breakdown

IBX NEU
Technical
61
77
Catalyst
50
50
Sentiment
50
50
Fundamental
11
60
Momentum
62
22
Risk Gate
37
43

Key Metrics

IBX Metric NEU
$10.3MMarket Cap$1.5B
2.0MAvg Volume (20d)705K
N/AShort Interest+4.4%
$0.05552-Week High$22.985
$0.01152-Week Low$8.610
+22.2%Daily Change+5.1%
$0.022Entry Price$11.880
N/AROE+8.7%
N/AProfit Margin+47.1%

Active Signals

IBX Signals

●MACD just crossed bullish — momentum is shifting to the upside
●Above-average volume (1.8x) on a green day — buyers stepping up
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●On a tear — up 15.8% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.8 quarters)
●4C filed 2026-01-28
●Very high P/S ratio (141.1x)

NEU Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is picking up steam
●Stochastic just turned bullish from a low level — early reversal sign
●Above-average volume (1.8x) on a green day — buyers stepping up
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Revenue in sharp decline (-81%)

Ask Scout AI to compare IBX and NEU in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
IBX Full Analysis → NEU Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).